|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Good Riddance to a Bad Drug
This op-ed, by one of the researchers who published a paper in 2001 arguing that Vioxx use gave rise to increased risk of heart attack, nicely puts forth the arguments in favor of stronger FDA standards for safety research and restrictions on direct-to-consumer advertising. Read it in tandem with the Journal piece.
|home spotlight commentary research events news about contact links archives|